PMC:7299399 / 23680-24577
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T106 | 504-511 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T83 | 125-133 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T84 | 368-387 | Disease | denotes | immune dysfunctions | http://purl.obolibrary.org/obo/MONDO_0005046 |
T85 | 415-423 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T86 | 705-712 | Disease | denotes | tetanus | http://purl.obolibrary.org/obo/MONDO_0005526 |
T87 | 717-727 | Disease | denotes | diphtheria | http://purl.obolibrary.org/obo/MONDO_0005504 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T238 | 426-429 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T239 | 430-431 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T240 | 590-591 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T241 | 642-643 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T242 | 752-753 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T149 | 63-72 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T150 | 137-146 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T151 | 185-194 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T152 | 461-470 | Chemical | denotes | adjuvants | http://purl.obolibrary.org/obo/CHEBI_60809 |
T153 | 504-511 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T154 | 619-623 | Chemical | denotes | alum | http://purl.obolibrary.org/obo/CHEBI_74768 |
T155 | 758-766 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
T156 | 829-834 | Chemical | denotes | water | http://purl.obolibrary.org/obo/CHEBI_15377 |
T157 | 847-855 | Chemical | denotes | squalene | http://purl.obolibrary.org/obo/CHEBI_15440 |
T158 | 864-878 | Chemical | denotes | polysorbate 80 | http://purl.obolibrary.org/obo/CHEBI_53426 |
T159 | 864-875 | Chemical | denotes | polysorbate | http://purl.obolibrary.org/obo/CHEBI_53422|http://purl.obolibrary.org/obo/CHEBI_53423|http://purl.obolibrary.org/obo/CHEBI_53424|http://purl.obolibrary.org/obo/CHEBI_53425 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T99 | 107-177 | Sentence | denotes | In the context of SARS-CoV-2, adjuvants are important for two reasons. |
T100 | 178-452 | Sentence | denotes | First, adjuvants might increase the efficacy of the vaccine, especially in subjects with impaired immunological function, such as the elderly, or in subjects with comorbidities resulting in immune dysfunctions; in these patient cohorts, SARS-CoV-2 has a high lethality rate. |
T101 | 453-611 | Sentence | denotes | Second, adjuvants can reduce the amount of vaccine protein(s) required per dose, which could facilitate scaling-up vaccine production in a reduced time frame. |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
348 | 125-135 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
349 | 398-405 | Species | denotes | patient | Tax:9606 |
350 | 415-425 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
373 | 822-825 | Chemical | denotes | oil | MESH:D009821 |
374 | 829-834 | Chemical | denotes | water | MESH:D014867 |
375 | 847-859 | Chemical | denotes | squalene oil | MESH:D013185 |
376 | 864-878 | Chemical | denotes | polysorbate 80 | MESH:D011136 |
377 | 705-712 | Disease | denotes | tetanus | MESH:D013746 |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32519842-30323958-158497 | 662-664 | 30323958 | denotes | 74 |
32519842-28734174-158498 | 736-738 | 28734174 | denotes | 75 |